[صفحه اصلی ]   [Archive]  
:: صفحه اصلي :: درباره نشريه :: آخرين شماره :: تمام شماره‌ها :: جستجو :: ثبت نام :: ارسال مقاله :: تماس با ما ::
بخش‌های اصلی
آرشیو مجله و مقالات::
برای نویسندگان::
برای داوران::
ثبت نام و اشتراک::
تماس با ما::
تسهیلات پایگاه::
بایگانی مقالات زیر چاپ::
::
جستجو در پایگاه

جستجوی پیشرفته
..
:: دوره 16، شماره 1 - ( 4-1401 ) ::
جلد 16 شماره 1 صفحات 21-16 برگشت به فهرست نسخه ها
Evaluation of lncRNA-HULC Level in the Plasma of Chronic HCV-Infected Patients
چکیده:   (1591 مشاهده)
Background and Aims: The main role of ncRNAs (non-coding RNAs) is to regulate various cellular activities. LncRNAs (long non-coding RNAs) are a group of ncRNAs that are over 200 base pairs in length. It has been shown that lncRNAs regulate and control various cellular functions. Disruption of the expression of lncRNAs can cause various disease and deficiency in the cell function. LncRNA-HULK is one of lncRNA, which is greatly increased in liver disorders, including hepatitis C. Recently, the use of HULK as a biomarker has been suggested as a prognostic factor for liver disease such as hepatocellular carcinoma. Therefore, this study aimed to investigate the level of lncRNA-Hulk in chronic HCV-infected patients.
Materials and Methods: The present study included 50 patients with chronic hepatitis C. After transferring the samples, total RNA was extracted and the quantity of HCV-RNA and lncRNA-HULK were determined using the real-time PCR assay. Finally, the relationship between HCV-RNA and lncRNA-HULK levels was evaluated.
Results: Of the total patients, 13 were female and 37 were male. All patients were HIV Ag/Ab and HBs Ag negative. Results showed that HCV-RNA level was 4,500-2,300,000 copies per mL of plasma. In addition, threshold cycles of lncRNA-HULK were calculated 28-38. Statistical analyses showed that there was a significant relationship between HCV-RNA level and lncRNA-HULK in the plasma of chronic patients.
Conclusion: In the recent study, the relationship between HCV-RNA quantity and lncRNA-HULC level in chronic hepatitis C patients was investigated. It is suggested that lncRNA-HULC levels could be considered as a biomarker in such patients. Accordingly, lncRNA-HULC quantification could be utilized to predict the progression of liver disease and the outcome in chronic HCV-infected patients.
متن کامل [PDF 536 kb]   (492 دریافت)    
نوع مطالعه: پژوهشي | موضوع مقاله: تخصصي
دریافت: 1400/3/27 | پذیرش: 1400/9/13 | انتشار: 1401/3/30
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

CAPTCHA


XML   English Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kazemi R, Aghasadeghi ‪ R, Rafiee A, motevalli F, Hamidi-Fard M. Evaluation of lncRNA-HULC Level in the Plasma of Chronic HCV-Infected Patients. Iran J Virol 2022; 16 (1) :16-21
URL: http://journal.isv.org.ir/article-1-449-fa.html

Evaluation of lncRNA-HULC Level in the Plasma of Chronic HCV-Infected Patients. مجله ویروس شناسی ایران. 1401; 16 (1) :16-21

URL: http://journal.isv.org.ir/article-1-449-fa.html



بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.
دوره 16، شماره 1 - ( 4-1401 ) برگشت به فهرست نسخه ها
Persian site map - English site map - Created in 0.04 seconds with 37 queries by YEKTAWEB 4645